Disc Medicine IRON
NASDAQ IRON
$64.51 +0.90 (+1.41%)
At close: Oct 2, 2026 · 4:00 PM EDT

Disc Medicine (IRON) Long-Term Investments (2020)

Updated

Disc Medicine's Long-Term Investments came in at $120.75 million for Q4 2020, unchanged from the prior quarter.

Analysis

Disc Medicine (IRON) Long-Term Investments (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 266.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 1.56 Bn
10 Disc Medicine 2.47 Bn 2.47 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 120.75 Mn
Sep 30, 2020 120.80 Mn
API Access

Disc Medicine Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=IRON&period=max&api_key=YOUR_API_KEY